Company ProfilePremium

Ultramarine & Pigments Ltd.

Company Profile Analysis

Ticker: ULTRAMAR.NS

ESOMAR 23 Corporate BadgeISO Certifications Badge
Ultramarine & Pigments Ltd. - Company showcase

Year Founded & Workforce

1960

1,256 Employees

Ultramarine & Pigments Ltd. logo

Ultramarine & Pigments Ltd. Employee Contacts

We don't hold contact details for this company yet — you can request them.

Request Employee Contacts

Ultramarine & Pigments Ltd. Overview

FieldDetail
Legal nameUltramarine & Pigments Limited
Former namesNone identified in available records
Founding / incorporationIncorporated October 1960 (25 October 1960 per IIFL company summary) in Bombay (now Mumbai); operations commenced 1961 (ICRA rationale, Oct 2025)
Incorporation jurisdictionMaharashtra, India (CIN: L24224MH1960PLC011856, per company letterheads in BSE filings)
Registered officeThirumalai House, Plot No. 101-102, Road No. 29, Near Sion Hill Fort, Sion (East), Mumbai 400 022, Maharashtra, India
Principal operating office / worksNo. 556, Vanagaram Road, Ambattur, Chennai 600 053, Tamil Nadu, India
Stock exchanges & tickersBSE Ltd: scrip code 506685; National Stock Exchange of India: symbol ULTRAMAR
ISININE405A01021
CUSIPNot applicable (no US listing)
Face value₹2 per share (split from ₹10 to ₹2 with a bonus issue, record date 18 October 2005)
Paid-up equity capital₹584 lakh as at 31 March 2026 (≈2.92 crore shares of ₹2 each) — FY2026 Directors' Report
Fiscal year end31 March
Employees (latest)1,256 permanent employees at end-FY2026 (624 in manufacturing; 632 in ITeS) — derived from gender-ratio disclosures in the FY2026 Directors' Report. Morningstar lists 1,072 (date of data not stated). 3-year trend: not publicly disclosed in sources reviewed
Statutory auditorSundaram & Srinivasan, Chartered Accountants, Chennai (FRN 004207S), appointed at the 63rd AGM on 25 July 2024 for a five-year term
Cost auditorGSVK & Co., Cost Accountants (FY2027)
Internal auditorM.S. Krishnaswamy & Co., Chartered Accountants
Secretarial auditorR.M. Mimani & Associates LLP (five-year term from the 65th AGM)
Registrar & transfer agentCameo Corporate Services Ltd, Chennai
Market capitalisation (current)≈₹1,198 Cr at a share price of ₹410.10 (NSE close, 7 October 2026, per 5paisa)
Credit rating[ICRA]A+ (Stable) long-term / [ICRA]A1+ short-term, reaffirmed 7 October 2025
Websitehttps://ultramarinepigments.net
Promoter groupSampath / Parthasarathy family; related listed company Thirumalai Chemicals Ltd (TCL)
Listing status vs. inputInput "Public company" — confirmed. Listed on BSE and NSE; small-cap.

The entity profiled is Ultramarine & Pigments Limited (commonly abbreviated "UPL" in its own filings and by ICRA; not to be confused with UPL Ltd, the agrochemical company). The name and the company type supplied ("Public company") are both correct: this is an active, publicly listed Indian company. No name-matching substitution was required.

Ultramarine & Pigments Limited is a six-decade-old, promoter-controlled Indian chemicals company headquartered legally in Mumbai and operationally in Chennai. Its core identity is as one of India's largest producers of ultramarine blue (Pigment Blue 29), an inorganic pigment used across plastics, paints, coatings, cosmetics, inks, laundry whitening and building applications, with adjacent lines in ultramarine violet and pink, bismuth vanadate yellow and complex inorganic colour pigments (CICPs). By revenue, however, the company is primarily a contract-style sulphonation and surfactants supplier to large FMCG detergent and personal-care makers in South India, which generated roughly 63% of FY2026 revenue. A smaller but higher-margin IT-enabled services (ITeS) arm handles publishing/content services and healthcare billing. The company is conservatively financed (ICRA gearing ~0.1x), consistently dividend-paying, and is now embarking on its largest pigment capex in history — a ₹250 Cr greenfield plant in Tamil Nadu.


What the company does

Ultramarine & Pigments operates three reportable business segments as disclosed in its quarterly segment reporting: (1) Chemicals and Allied Products, which contains both inorganic pigments and surfactants/specialities; (2) IT-Enabled Services (ITeS), including BPO activity; and (3) Windmill (wind power generation), which is primarily captive. Morningstar's business description and the company's Q3 FY2026 filing confirm this three-segment structure.

Inorganic pigments. The company manufactures ultramarine blues (Pigment Blue 29), ultramarine violet (Pigment Violet 15), ultramarine pink (Pigment Red 259), bismuth vanadate (Pigment Yellow 184), and complex inorganic colour pigments/mixed metal oxides. The company's website emphasises "environmentally friendly" pigments usable across paints, plastics, inks, laundry and cosmetics. ICRA notes that high-grade ultramarine is used in plastics, paints, coatings, cosmetics, food and detergents, while lower grades go into whitewash and laundry applications. Pigments are made at Ambattur (Chennai) and Ranipet in Tamil Nadu by the parent, and at Naidupeta, Andhra Pradesh, by wholly owned subsidiary Ultramarine Specialty Chemicals Ltd (USCL), whose capacity reached 3,550 MTPA after an expansion completed in FY2026.

Surfactants and specialities. The company is a sulphonator producing linear alkyl benzene sulphonic acid (LABSA), alpha olefin sulphonate (AOS) and sodium lauryl ether sulphate (SLES), plus a growing basket of specialty/cosmetic-grade surfactants: medium chain triglyceride (MCT), benzalkonium chloride (BKC), cocamidopropyl betaine (CAPB), coco mono-ethanolamide (CMEA), coco diethanolamide (CDEA), cocamidopropylamine oxide (CAPAO), disodium laureth sulfosuccinate (DLESS) and lauryl amine oxide (LAO). It also sells detergent powder/liquid under the brand "OOB" (per ICRA). ICRA describes the company as among the key suppliers of surfactants to detergent manufacturers in South India, including large multinational FMCG players. Surfactants are produced at Ranipet (Tamil Nadu) and Naidupeta (Andhra Pradesh).

IT-enabled services. Started in 2000 under the leadership of current Vice Chairperson Indira Sundararajan, the ITeS division operates from Chennai and Ranipet and is commonly referenced as "Lapiz Digital Services" (third-party listing) alongside a customer/broadcast services unit. ICRA characterises it as specialising in content management, publishing and hospital billing services. In FY2026, ITeS income was ₹52 Cr with segment profit of ₹15 Cr.

Wind power. The company owns seven wind turbine generators at three Tamil Nadu locations with total capacity of 5 MW (FY2025: 4.3 MW), generating 80 lakh units in FY2026, all captively consumed at the Ranipet and Ambattur plants.

Business model and revenue model

Revenue model componentDescriptionFY2026 indicative share of consolidated revenue
Product sales — surfactants & specialitiesVolume-driven B2B supply to FMCG detergent and personal-care makers; pricing largely linked to feedstock (LAB, alpha olefins, fatty alcohols/ethoxylates) with limited value addition per ICRA≈63% (₹489 Cr of ₹775 Cr)
Product sales — inorganic pigments (parent)B2B sales to plastics, coatings, inks, cosmetics, laundry and building-materials customers, domestic and export≈21% (₹164 Cr)
Product sales — inorganic pigments (subsidiary USCL)Ultramarine and CICP output from Naidupeta≈10% (₹74 Cr, gross of any intercompany)
Services — ITeS/BPOFee-for-service publishing, content management, healthcare billing≈7% (₹52 Cr)
Captive powerWind generation consumed internally; small reported segment revenue<1%
Subscription / licensing—0%

Note: Segment figures are from the FY2026 Directors' Report; shares are derived and sum to slightly more than 100% because subsidiary revenue may include intercompany sales and divisional figures are not reconciled one-for-one with consolidated revenue in the report.

Value-chain position

The company sits in the mid-stream of two chemical chains. In surfactants it converts petrochemical and oleochemical intermediates (LAB, alpha olefins, fatty alcohol ethoxylates, coconut-derived amides) into anionic and amphoteric surfactants sold to consumer-goods formulators — a position with limited pricing power, as ICRA explicitly notes. In pigments it is closer to a specialty manufacturer, converting minerals and commodity inputs (kaolin/china clay, soda ash, sulphur, silica and reducing agents for ultramarine; bismuth and vanadium compounds for BiVaN; metal oxides for CICPs) into finished colorants. ITeS is a separate services value chain.

Customer types and end-markets

End-marketProductsCustomer type
Home care / laundry detergentsLABSA, AOS, SLES, OOB detergents, laundry-grade ultramarineLarge MNC and domestic FMCG players, regional detergent makers
Personal care & cosmeticsSLES, CAPB, amine oxides, DLESS, MCT, cosmetic-grade ultramarineFMCG and cosmetics formulators
Plastics & masterbatchUltramarine blue/violet, BiVaN, CICPsCompounders, masterbatch makers
Paints & coatingsUltramarine, BiVaN, CICPsPaint and coatings manufacturers
Printing inksUltramarine gradesInk makers
Building materials / whitewashLower-grade ultramarineConstruction-chemicals and whitewash makers
Disinfection / institutionalBKCHygiene-product manufacturers
Publishing & healthcare (ITeS)Content/publishing services; hospital billingGlobal publishers; healthcare providers

Company's own description vs. independent characterisation

The company describes itself on its website as "a leading manufacturer of inorganic pigments and surfactants" with a legacy of over 60 years, a client base across more than 50 countries, and a focus on quality, certifications (ISO 9001/14001/45001 per letterheads) and social responsibility. Its FY2026 Management Discussion attributes the year's growth to surfactants volumes and realisations, notes that export markets beyond the US offset tariff impacts, and flags rising input costs from West Asia disruptions.

Independent characterisation: UPL is best understood as a cash-generative, low-leverage surfactant converter with a niche global pigments franchise and a non-core but profitable services arm. Its brand identity rests on ultramarine, but its earnings mass increasingly rests on surfactants, which ICRA flags as low value-add. Margins have structurally reset from 23–25% (FY2019–FY2021) to 16–18% (FY2022–FY2026) as the surfactant mix rose. The balance sheet is dominated by a large equity investment in group company Thirumalai Chemicals, which introduces mark-to-market volatility and governance considerations unrelated to operating performance. The ₹250 Cr Manapparai greenfield is an explicit attempt to re-weight the portfolio back toward pigments.

Strategy

Stated strategic themes (FY2026 Annual Report and website, paraphrased)

  1. Product-mix upgrade in surfactants — developing and adding high-value specialty chemicals to optimise revenue and margins.

  2. Pigment capacity and diversification — completing USCL expansion (3,550 MTPA), building the Manapparai greenfield, and broadening beyond ultramarine into BiVaN and CICPs.

  3. Export market diversification — offsetting US tariff impacts with volumes in other markets.

  4. Green energy — wind capacity increased to 5 MW; green energy now 52% of total consumption (FY2025: 45%).

  5. Operational excellence and governance — ERP-based controls, ERM framework, succession planning and leadership development.

  6. Vision statement (website): global leadership and becoming the preferred choice while enhancing stakeholder value; quality, cost-effective and eco-friendly technologies; continual improvement; career development.

Strategic initiatives — last 24 months

DateInitiativeScale / targetStatus
Dec 2024SIPCOT Manapparai land (32.12 acres)99-year leaseCompleted
FY2026USCL pigment expansion, NaidupetaCapacity to 3,550 MTPACompleted; CICP utilisation below plan
FY2026Wind capacity addition4.3 MW → 5 MWCompleted
FY2026New product commercialisation1 product + several gradesCompleted; pipeline exists
20 May 2026Greenfield inorganic pigments plant, Manapparai₹250 Cr; 2,500 MTPA; phased FY2028 and FY2029; funded by internal accruals + term loansApproved; early stage
Dec 2025Strategic investment in TCL preferential issue₹45 CrCompleted
Apr 2026Inter-corporate loan to TCL₹65 Cr, 3 years, 10%Executed
Nov 2025New Labour Codes compliance₹1.71 Cr one-time costCompleted

Capital intensity of greenfield (derived): ₹250 Cr ÷ 2,500 MT = ₹10 lakh per tonne of capacity. The project equals ~32% of FY2026 consolidated revenue and ~21% of current market capitalisation.

Medium-term financial targets / guidance

The company does not publish quantified guidance, medium-term revenue or margin targets, and does not hold earnings calls or investor days identified in reviewed sources. Management's qualitative outlook (FY2026 MD&A): export growth supported by lower US tariffs; continuing risk from West Asia-driven input inflation, supply-chain instability, austerity measures and rising fuel costs.

Products & Services

Pricing models are not publicly disclosed for any product; the company sells B2B on negotiated contracts or spot terms. Launch years are not disclosed for individual grades unless stated.

5A. Inorganic Pigments (Chemicals & Allied Products segment)

ProductColour IndexDescription & key capabilitiesTarget customersNotes
Ultramarine BluePigment Blue 29Sodium aluminosilicate-sulphur complex pigment; non-toxic, heat-stable, alkali-resistant; multiple grades from high-purity cosmetic/plastics grades to laundry/whitewash gradesPlastics, masterbatch, paints, coatings, inks, cosmetics, detergents/laundry, building materialsFlagship; ICRA identifies it as the dominant pigment revenue source and a concentration risk
Ultramarine VioletPigment Violet 15Violet analogue of ultramarine; used for reddish shading and cosmeticsCosmetics, plastics, coatingsNiche
Ultramarine PinkPigment Red 259Pink ultramarine derivativeCosmetics, specialty plasticsNiche
Bismuth VanadatePigment Yellow 184High-chroma, heavy-metal-free yellow; substitute for lead chromate and cadmium yellowsAutomotive/industrial coatings, plasticsHigher-value diversification product
Complex Inorganic Colour Pigments (CICPs) / mixed metal oxidesVariousHigh-temperature-calcined pigments with extreme weatherability and heat stabilityCoil coatings, engineering plastics, ceramics, building materialsProduced at USCL's CICP plant, Naidupeta; utilisation below plan in FY2026

Capacity (ICRA, Oct 2025): 9,715 MTPA total pigment capacity (group). USCL capacity 3,550 MTPA post FY2026 expansion. Planned additional 2,500 MTPA at Manapparai (FY2028–FY2029).

5B. Surfactants (Chemicals & Allied Products segment)

ProductTypeDescriptionTarget customers
Linear Alkyl Benzene Sulphonic Acid (LABSA)AnionicPrimary active in detergent powders, bars and liquids; first sulphonation product (1996, 16,000 MTPA initial)Detergent manufacturers
Alpha Olefin Sulphonate (AOS)AnionicHigh-foaming, hard-water-tolerant surfactantLiquid detergents, shampoos, hand wash
Sodium Lauryl Ether Sulphate (SLES)AnionicMild, high-foaming surfactant for personal care and dishwashPersonal care, dishwash formulators

Capacity (ICRA, Oct 2025): 62,000 MTPA surfactants. Ranipet reported at optimum utilisation in FY2026; Naidupeta utilisation improving.

5C. Specialty Chemicals (Chemicals & Allied Products segment)

ProductAbbreviationFunctionEnd-use
Medium Chain TriglycerideMCTEmollient/carrier oilCosmetics, personal care
Benzalkonium ChlorideBKCCationic biocide/disinfectantHygiene, disinfectants
Cocamidopropyl BetaineCAPBAmphoteric co-surfactant, mildness boosterShampoos, body wash
Coco Mono Ethanol AmideCMEAFoam booster/thickenerShampoos, detergents
Coco DiethanolamideCDEAFoam stabiliser/thickenerPersonal care, household
Cocamidopropylamine OxideCAPAOAmphoteric co-surfactantDishwash, personal care
Disodium Laureth SulfosuccinateDLESSMild anionic surfactantBaby care, sulphate-free formulations
Lauryl Amine OxideLAOFoam booster, grease cuttingDishwash, hard-surface cleaners

FY2026 Directors' Report: one new product was commercialised and several new grades added; more are in the pipeline using existing infrastructure. Specific product names for FY2026 launches are not disclosed.

5D. Detergents (Chemicals & Allied Products segment)

BrandProductNotes
OOBDetergent powder and liquidBrand named by ICRA; small scale; market share not disclosed

5E. IT-Enabled Services (ITeS segment)

Service lineDescriptionTarget customers
Publishing & content management (reported as "Lapiz Digital Services" in third-party listings)Digital publishing, typesetting/content conversion, content managementInternational publishers
Hospital/medical billingRevenue-cycle services for healthcare providersHealthcare providers (geography not disclosed)
Customer / broadcast services (BPO)Customer-contact and related BPO services—

Delivery centres: Chennai and Ranipet. FY2026: 632 employees, 50% women. Management cited focus on service quality, process automation and business development.

5F. Windmill (Windmill segment)

AssetCapacityFY2026 outputUse
7 wind turbine generators, 3 Tamil Nadu sites5 MW (FY2025: 4.3 MW)80 lakh units (FY2025: 57 lakh)100% captive at Ranipet and Ambattur

Financial Narrative

Source: Consolidated financials as compiled by Screener.in from annual reports (FY2022–FY2026), cross-checked against the FY2026 Directors' Report (revenue ₹774.77 Cr, PBT ₹104.67 Cr, PAT ₹80.77 Cr), ICRA rationale (FY2024–FY2025), and Business Standard/Capital Market result summaries. Screener rounds to whole crores.

Income statement (INR Cr)

Operating income (EBIT): derived as EBITDA less depreciation: FY2022 ₹72 Cr; FY2023 ₹85 Cr; FY2024 ₹73 Cr; FY2025 ₹95 Cr; FY2026 ₹99 Cr. Basic and diluted EPS are identical (no dilutive instruments; no ESOPs per FY2026 report).

Margins and growth (%)

CAGRs (derived): Revenue FY2022–FY2026: 12.1%. Net profit FY2022–FY2026: 8.7%. EPS FY2022–FY2026: 8.5%. Screener reports 5-year sales CAGR of 20% (FY2021 base of ₹308 Cr, before the surfactant step-up) and 5-year profit CAGR of 7%.

Commentary. FY2022 was the inflection year: revenue jumped 59% as surfactant volumes and feedstock-driven prices rose, but EBITDA margin collapsed from ~25% (FY2020–FY2021) to 17% because surfactants are pass-through, low-margin products. ICRA attributes the margin reset (23–25% in FY2019–FY2021 to 17–18% in FY2022–FY2025) to high raw material prices and the higher surfactant contribution. FY2024 was a pause year — revenue flat and PAT down 16% as depreciation rose with USCL's commissioning and interest costs rose on its term loan. FY2025 delivered 24% revenue growth on higher realisations and volumes (ICRA). FY2026 grew 11.5% (surfactants +14%) but margins slipped to 16.3% as Q4 input costs surged following West Asian geopolitical events; PBT rose only 5%. Depreciation has more than doubled since FY2022 (₹12 Cr to ₹27 Cr) reflecting the USCL build-out, which is still under-utilised.

Quarterly trajectory (INR Cr, consolidated)

Sources: Capital Market/Business Standard summaries (Q1FY26, Q2FY26, Q1FY27), company Q3/Q4 filings via ScanX/Trendlyne. Q2FY26 and Q1FY27 EPS derived from PAT ÷ 2.92 crore shares. Q3FY26 PAT includes a net exceptional gain of ₹4.26 Cr (NHAI land compensation ₹5.77 Cr + ₹0.20 Cr interest, less ₹1.71 Cr labour-code charge). Q1FY27 OPM was 18.95% vs 17.24% in Q1FY26; PBDT rose 51% to ₹49.72 Cr.

Q1 FY2027 inflection: Revenue up 30% YoY and PAT up 56% — the strongest quarter in company history, coming immediately after the weakest quarter of FY2026. Drivers were not explained in reviewed summaries; plausible contributors (not confirmed by management) include price pass-through of Q4 input cost spikes, USCL ramp-up and export recovery after US tariff reductions referenced in the FY2026 MD&A. TTM PAT (Q2FY26–Q1FY27) = ₹92.2 Cr; TTM EPS ≈ ₹31.6.

Balance sheet (INR Cr, consolidated, 31 March)

Net debt (derived, FY2025): ₹94 Cr borrowings (Screener basis) − ₹74.23 Cr cash & liquid investments (ICRA) ≈ ₹20 Cr; on ICRA's external term loan basis (₹85.79 Cr) ≈ ₹11.6 Cr. Excluding strategic equity investments, the company is near net-debt-neutral.

The investment line is the dominant balance-sheet swing factor. The ₹376–551 Cr investment book consists principally of the company's equity stake in Thirumalai Chemicals (carried at fair value through OCI) plus mutual fund treasury holdings. Reserves fell from ₹967 Cr to ₹864 Cr in FY2026 despite ₹81 Cr of profit — consistent with a decline in TCL's share price. In Q1 FY2026 alone the company booked an unrealised OCI gain of ₹551 Cr on investments (FilingReader summary of the filing), illustrating the magnitude of this exposure relative to operating earnings. Book value is therefore heavily influenced by a single related-party equity holding.

Cash flow (INR Cr)

Capex derived as CFO minus Screener FCF. Dividends paid derived as prior-year DPS × 2.92 crore shares. No buybacks have been authorised or executed in the period.

Commentary. Cash conversion has improved markedly: CFO/EBITDA rose from 56% in FY2022 (working-capital build during the surfactant price spike) to 118% in FY2026 as working-capital days fell from 82 to 43. FY2026 FCF of ₹62 Cr was the highest in the period. The large FY2026 investing outflow (₹148 Cr) reflects capex plus the ₹45 Cr subscription to TCL's preferential issue and treasury movements. FY2027 investing outflows will rise further with the ₹65 Cr loan to TCL (April 2026) and the start of the ₹250 Cr Manapparai project.

Ratio analysis

Derived ratios use Screener-rounded inputs. ROE FY2022 uses FY2021 equity of ~₹461 Cr. ICRA's own calculations: interest coverage 13.1x (FY2024), 16.4x (FY2025), 19.0x (Q1 FY2026); total debt/OPBDITA 0.8x (FY2024 and FY2025); TOL/TNW 0.2x. Current ratio and ROIC: not publicly disclosed in reviewed sources. Net debt/EBITDA: ≈0.2x for FY2025 (derived); other years not verifiable.

Commentary. Return ratios are structurally depressed (ROE 7–9%) not because operations are weak but because roughly a third to half of equity is tied up in the TCL stake and treasury investments that generate little P&L return. On an operating basis (EBIT ≈ ₹99 Cr against net fixed assets plus working capital of very roughly ₹500 Cr), operating returns are meaningfully higher than headline ROE — though a precise operating ROIC cannot be verified. Leverage is minimal and interest coverage strong; ICRA's downgrade trigger is TD/OPBDITA above 1.8x on a sustained basis. The working-capital cycle improved materially in FY2026.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Financial Detail

Group Entities

EntityRelationshipIncorporatedStatusNotes

Ultramarine & Pigments Ltd

Listed parent

Oct 1960, Mumbai

Operating

Pigments (Ambattur, Ranipet), surfactants (Ranipet, Naidupeta), ITeS, wind

Ultramarine Specialty Chemicals Ltd (USCL)

100% subsidiary; "material subsidiary" under SEBI LODR

9 Dec 2019, Chennai

Operating since Aug 2022

Naidupeta, AP pigments incl. CICP plant; auditor Brahmayya & Co.; recommended 7.5% preference dividend (Jul 2025)

Ultramarine Fine Chemicals Ltd

100% subsidiary

FY2022/FY2023

Not yet commenced operations

Purpose not detailed in reviewed filings

Segment Overview

SegmentContentsKey products

Chemicals and Allied Products

Inorganic pigments (parent + USCL) and surfactants/specialities and detergents

Ultramarine blue/violet/pink, BiVaN, CICPs; LABSA, AOS, SLES, specialty surfactants, OOB detergent

IT-Enabled Services

ITeS and BPO

Publishing/content management, hospital billing, customer services

Windmill

Wind turbine generators

Captive power (5 MW)

Revenue by Segment

Division (INR Cr, FY2026 Directors' Report)FY2025FY2026

Surfactants & Specialities revenue (INR Cr)

430489

Inorganic Pigments — parent revenue (INR Cr)

175164

Inorganic Pigments — USCL subsidiary revenue (INR Cr)

5474

ITeS income (INR Cr)

4552

Consolidated revenue from operations (INR Cr)

695775

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Segment Revenue

DivisionFY2026 YoY growthFY2026 % of consolidated revenue (derived)FY2025 % of consolidated revenue (derived)

Surfactants & Specialities

+13.7%63.1%61.9%

Pigments — parent

−6.3%21.2%25.2%

Pigments — USCL

+37% (company-stated)

9.5%7.8%

Pigments — combined (gross)

+3.9% (238 vs 229)

30.7%32.9%

ITeS

+15.6%6.7%6.5%

Results by Segment

Metric (INR Cr)FY2025FY2026

ITeS segment profit (INR Cr)

015

Income Statement and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Revenue from operations (INR Cr)

490557561695775

Operating expenses (INR Cr)

406455466576649

EBITDA excl. other income (INR Cr)

8410295119126

Other income (INR Cr)

911101213

Depreciation (INR Cr)

1217222427

Interest (INR Cr)

45777

Profit before tax (INR Cr)

789176100105

Net profit (INR Cr)

5869587581

EPS basic/diluted (INR)

19.9723.7019.7325.7027.66

Dividend per share (INR)

55566

Effective tax rate (%)

2524242523

Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

EBITDA margin (%)

17.118.316.917.116.3

EBIT margin (%)

14.715.313.013.712.8

PBT margin (%)

15.916.313.514.413.5

Net margin (%)

11.812.410.310.810.4

Revenue growth YoY (%)

59.113.70.723.911.5

Net profit growth YoY (%)

3.619.0-15.929.38.0

Dividend payout (%)

2521252322

Income Statement and Per-Share Data (Quarterly)

MetricQ1FY26Q2FY26Q3FY26Q4FY26Q1FY27

Revenue from operations (INR Cr)

184.38196.07195.60198.71239.96

Profit before tax (INR Cr)

26.5525.8133.9318.3842.38

Net profit (INR Cr)

20.1919.3627.0914.1531.59

EPS (INR)

6.916.639.284.8510.82

Balance Sheet and Per-Share Data

MetricFY2022FY2023FY2024FY2025FY2026

Total assets (INR Cr)

9958811,0761,1731,094

Net fixed assets (INR Cr)

152238281334373

Capital work in progress (INR Cr)

6929302630

Investments (INR Cr)

551366492513376

Other assets incl. working capital and cash (INR Cr)

222248274299315

Borrowings total (INR Cr)

5375799486

Other liabilities (INR Cr)

827097106138

Shareholders' equity (INR Cr)

860736900973870

Book value per share (INR)

294252308333298

Cash Flow and Margin Analysis (%)

MetricFY2022FY2023FY2024FY2025FY2026

Operating cash flow (INR Cr)

29627890128

Capex derived (INR Cr)

6961635366

Free cash flow (INR Cr)

-401153762

Investing cash flow total (INR Cr)

-63-55-51-42-148

Financing cash flow (INR Cr)

-7-2-18-33-31

Dividends paid approx derived (INR Cr)

1515151518

Share buybacks (INR Cr)

00000

CFO to EBITDA (%)

568110094118

Returns & Leverage Ratios (%) and Financial Ratios (x)

RatioFY2022FY2023FY2024FY2025FY2026

ROE on average equity (%)

8.88.67.18.08.8

ROA on closing assets (%)

5.87.85.46.47.4

ROCE per Screener (%)

111191011

Debt to equity (x)

0.060.100.090.100.10

Interest coverage EBITDA to interest (x)

21.020.413.617.018.0

Asset turnover (x)

0.490.630.520.590.71

Debtor days

2929384238

Inventory days

931131098388

Payable days

5253694969

Cash conversion cycle (days)

7189797656

Revenue by Region and Revenue by Region (%)

MetricFY2025FY2026

Consolidated export revenue (INR Cr)

211226

Consolidated domestic revenue derived (INR Cr)

484549

Standalone export revenue (INR Cr)

184176

Standalone domestic revenue derived (INR Cr)

467531

Consolidated export share (%)

30.429.2

Geography Overview

GeographyFY2026 YoY growth

Consolidated exports

+7.1%

Consolidated domestic (derived)

+13.4%

Standalone exports

−4.3%

Subsidiary-driven exports (derived: consolidated minus standalone)

₹27 Cr → ₹50 Cr (+85%)

Markets

MarketDisclosureSource

United States

5–8% of total revenues; tariff impact expected to be limited

ICRA, Oct 2025

South Korea, Europe

Named export destinations

ICRA, Oct 2025

India — South

Core surfactant market; supplies MNC FMCG players

ICRA

Global reach

Clients in over 50 countries

Company website

Valuation Snapshot

MetricValueSource / date

Last price

₹410.10

NSE close, 7 Oct 2026 (5paisa)

Market capitalisation

≈₹1,198 Cr

5paisa, 8 Oct 2026

52-week high / low

₹490 / ₹364 (low on 19 Jun 2026)

5paisa; Business Standard

All-time high

₹613.95 (21 Jul 2025)

Business Standard

50-DMA / 200-DMA

₹412.80 / ₹415.70

5paisa

Average daily volume (sample day)

~28,000 shares (7 Oct 2026)

5paisa — thinly traded

Return period

Return

—

1 month

−6.1% (5paisa, Oct 2026)

—

3 months

+6.6% (5paisa)

—

6 months

+3.3% (5paisa)

—

1 year

−8.9% (5paisa)

—

3-year CAGR

~2% (Screener, as of late Jul 2026)

—

5-year CAGR

~1% (Screener, as of late Jul 2026)

—

10-year CAGR

~10% (Screener, as of late Jul 2026)

—

Valuation Snapshot by Multiple

MultipleValueBasis

P/E (TTM)

~13.0x

₹410 ÷ TTM EPS ₹31.6 (Q2 FY26–Q1 FY27)

P/E (FY2026)

~14.8x

₹410 ÷ ₹27.66

P/B

~1.38x

₹410 ÷ FY2026 BVPS ₹298 (5paisa shows 1.3x)

EV/Sales (FY2026)

~1.6x

EV ≈ ₹1,198 Cr mcap + ₹86 Cr debt − ~₹53 Cr cash (aggregator) ≈ ₹1,231 Cr

EV/EBITDA (FY2026)

~9.8x

₹1,231 Cr ÷ ₹126 Cr

EV/EBITDA adjusted for investments

~6.8x

Further deducting ~₹376 Cr investment book (TCL stake + treasury) — illustrative

Dividend yield

~1.5%

₹6 ÷ ₹410

Per-Share Data

MetricFY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026

Dividend per share (INR)

4.55555566

Credit Ratings

AgencyInstrumentRatingOutlookDate

ICRA

Long-term fund-based cash credit (₹1.00 Cr)

[ICRA]A+

Stable

7 Oct 2025

ICRA

Long-term term loan (₹16.60 Cr)

[ICRA]A+

Stable

7 Oct 2025

ICRA

LT/ST fund/non-fund based (₹5.00 Cr)

[ICRA]A+ / [ICRA]A1+

Stable

7 Oct 2025

ICRA

Short-term non-fund based (₹15.00 Cr)

[ICRA]A1+

—

7 Oct 2025

Moody's / S&P / Fitch

—

Not rated

——

Capital Markets

ItemDetail

External term loan outstanding (31 Mar 2025)

₹85.79 Cr (ICRA)

Due within FY2026

~₹18.87 Cr

Rated term loan

₹16.60 Cr; issued Dec 2019; 8.4%; final maturity June 2028

Working-capital limits

Largely unutilised (ICRA)

Prospective

Manapparai greenfield to be part-funded by new term loans (amount not disclosed)

Analyst Conclusions

Management guidance

No quantitative guidance is issued. Qualitative outlook (FY2026 MD&A): export growth supported by lower US tariffs; continued pressure from West Asia-linked input costs, supply-chain instability, austerity and fuel costs; continued focus on specialty surfactants and new pigment products; greenfield capacity in FY2028–FY2029.

Consensus expectations

None available (no sell-side coverage). Run-rate observation: Q1 FY2027 annualised revenue ≈ ₹960 Cr and PAT ≈ ₹126 Cr, but a single quarter following a weak Q4 should not be extrapolated.

Bull case

  1. Earnings inflection is underway. Q1 FY2027 revenue +30% and PAT +56% with OPM expanding to 18.95% suggests pricing power returned after Q4's cost spike and that USCL capacity is beginning to contribute; even modest continuation implies FY2027 PAT well above FY2026's ₹81 Cr.

  2. Pigment re-weighting improves quality of earnings. USCL (3,550 MTPA) plus the 2,500 MTPA Manapparai plant would lift pigments' share from ~31% of revenue, structurally raising group margins toward historical 20%+ levels — the precise mix effect ICRA identified as the cause of the margin decline.

  3. Valuation is undemanding with asset backing. At ~13x TTM P/E and ~1.4x book, with ~₹376 Cr of investments (≈31% of market cap) and A+ credit, downside is cushioned while the company funds growth largely internally.

Bear case

  1. Capital allocation is drifting toward the promoter group. In five months UPL deployed ~₹110 Cr into TCL (₹45 Cr equity + ₹65 Cr unsecured loan) — more than FY2026 PAT — while TCL reported a wider FY2026 consolidated loss; minority shareholders bear credit and equity risk on a related party.

  2. Commodity-like core and execution risk. Surfactants (63% of revenue) are low value-add per ICRA; USCL's CICP plant has already disappointed on utilisation; a ₹250 Cr greenfield adds depreciation and debt ahead of uncertain demand, risking a repeat of FY2024's flat-earnings year.

  3. Structural return problem. ROE has not exceeded ~9% in five years; volatile OCI swings on the TCL stake drive book value; thin liquidity, ~2% institutional ownership and no guidance limit rerating catalysts.

Key catalysts and monitorables (next 12 months)

Catalyst / monitorableTimingWhat to watch
Q2 FY2027 results~Nov 2026Sustainability of Q1 margin (18.95%) and revenue (~₹240 Cr)
SAST disclosure detailsImmediateWhether TCL bought from market or intra-group; implications for promoter stake
TCL loan servicingOngoingInterest receipts at 10%; any extension or increase
Manapparai greenfieldFY2027Debt raised, ground-breaking, cost discipline
USCL utilisationQuarterlyCICP plant ramp; subsidiary PAT (third-party summary of Q1 FY2027 filing indicates USCL quarterly PAT ~₹3.5 Cr on ~₹24.8 Cr income)
Input costsOngoingLAB/alpha olefin prices; West Asia developments
US tariff regimeOngoingPigment export volumes
ICRA surveillance~Oct 2026Rating action in light of capex and related-party loans
Q4 FY2027 / dividendMay 2027Whether dividend rises above ₹6

Analyst verdict

Ultramarine & Pigments is a well-run, conservatively financed small-cap whose operating franchise is better than its headline returns suggest and whose capital allocation is less disciplined than its balance sheet suggests. The operating core — a 65-year ultramarine franchise, an entrenched surfactant supply position with multinational FMCG customers, and a quietly profitable ITeS arm — has compounded revenue at ~12% over four years, generated rising free cash flow (₹62 Cr in FY2026), and maintained EBITDA margins well above larger Indian peers such as Galaxy Surfactants and Sudarshan Chemical. Q1 FY2027's record quarter demonstrates that pricing can recover quickly after input shocks.

The investment case, however, is clouded by three issues. First, the business mix has drifted toward low-value surfactants, compressing margins from ~25% to ~16%; the Manapparai greenfield is the right strategic response but carries execution risk evidenced by USCL's under-utilised CICP plant. Second, nearly a third of the market capitalisation and a large share of book value sit in a related-party equity stake whose price swings dwarf operating profit, depressing ROE to 7–9% and making reported net worth volatile. Third, and most importantly, the ₹110 Cr deployed into Thirumalai Chemicals between December 2025 and April 2026 — on top of the existing cross-holding, and followed by unexplained SAST movements in October 2026 — signals that surplus cash may be steered toward group needs rather than minority-shareholder returns.

At roughly 13x trailing earnings, ~1.4x book, ~10x EV/EBITDA (lower if investments are netted) and an A+ credit, the valuation already discounts much of this. The stock is best characterised as value with a governance discount.

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Executive Leadership

Board of Directors

NameDesignationCategoryTenure / background

R. Sampath

Chairman

Non-Executive, Promoter

Joined 1970 as Project Engineer; MD 1990; CMD 1998–Mar 2016; Non-Executive Chairman since. B.Sc. Chemistry (Univ. of Bombay); Chemical Engineering degree, Washington State University

Indira Sundararajan

Vice Chairperson

Executive/Promoter group (designation per website)

B.Sc.(Tech), gold medallist, UDCT (now ICT) Mumbai; founded ITeS division 2000; WTD 2012; VC & MD from 2015

Tara Parthasarathy (DIN 07121058)

Managing Director

Executive, Promoter group

B.Tech (Anna University); Master of Environmental Management (Yale); JMD 2015; heads sulphonation; signed FY2026 Board's Report; re-appointed by rotation at 65th AGM (22 Jul 2026)

V. Bharathram

Managing Director

Executive, Promoter group

Computer Science graduate, MBA; MD since 2019; oversees pigments & surfactants; CSR Committee member

R. Senthil Kumar (DIN 07506927)

Whole-time Director

Executive

Former GM – Operations; WTD since 1 Aug 2016; runs Ambattur and Ranipet plants

C.R. Chandra Bob

Independent Director

Independent

CSR Committee Chairman

Harsh R. Gandhi

Independent Director

Independent

—

B.K. Sethuram(an)

Independent Director

Independent

—

Hemalatha Mohan

Independent Director

Independent

CSR Committee member

R. Ravi Shankar

Independent Director

Independent

—

Governance Overview

AttributeDetail

Board size

10

Independent directors

5 (50%)

Women directors

3 (Indira Sundararajan, Tara Parthasarathy, Hemalatha Mohan)

Chair/CEO separation

Yes — Non-Executive Chairman; executive leadership shared by two MDs and a Vice Chairperson

Lead Independent Director

Yes (named role; individual not identified in excerpt)

Board meetings FY2026

Six

Committees

Audit; Nomination & Remuneration; CSR; Stakeholders Relationship; Risk Management

Risk Management Committee meetings FY2026

25 Sep 2025; 13 Mar 2026

Independent Directors' meetings FY2026

19 Sep 2025; 18 Mar 2026

Board & Management Changes

DateChange

22 Jul 2026

Tara Parthasarathy re-appointed (retirement by rotation)

22 Jul 2026

R.M. Mimani & Associates LLP appointed Secretarial Auditor for five years

25 Jul 2024

Sundaram & Srinivasan appointed statutory auditors

Major Shareholders

Holder category (30 Jun 2026, per 5paisa)%

Promoter & promoter group

40.49

Foreign institutional investors

1.42

Other institutions (DIIs)

0.64

Public (retail & others)

57.45

Major Shareholders by Holder

HolderStakeSource / date

Thirumalai Chemicals Ltd (promoter group)

14.38%

MarketsMojo, Mar 2026 shareholding

Competitive Landscape

Competitors by Segment

SegmentCompetitorHQPositioning vs UPL

Ultramarine pigments (global)

Holliday Pigments (carved out of Venator; acquired by Mutares in 2026)

Comines, France

Self-described #2 globally in technical-grade ultramarine; ~EUR 30m revenue, 115 employees (Mutares)

Ultramarine / inorganic pigments

Vibrantz Technologies (owner of Nubiola ultramarine and CICP lines; formerly Ferro)

USA/Spain

—

Ultramarine pigments

Chinese ultramarine producers (multiple)

China

Low-cost competition; ICRA cites competition from global players

Inorganic & organic pigments (India/global)

Sudarshan Chemical Industries (incl. acquired Heubach business)

Pune, India

Much larger diversified pigment major; FY2026 revenue ₹9,787 Cr

Organic pigments (India)

Asahi Songwon Colors

Ahmedabad, India

Phthalocyanine blue leader; adjacent rather than direct

Pigments/colorants (India)

Kiri Industries, Bodal Chemicals, Poddar Pigments

India

Listed peers in dyes & pigments classification; limited direct overlap

BiVaN & CICPs

Sun Chemical/DIC (ex-BASF pigments), Shepherd Color, Heubach (Sudarshan)

Global

Technology leaders in high-performance inorganic pigments

Surfactants (India)

Galaxy Surfactants

Navi Mumbai, India

Largest Indian oleochemical surfactant maker; FY2026 revenue ₹5,248 Cr

Surfactants (India)

Aarti Surfactants

India

—

Surfactants (global/India)

Clariant, BASF, Croda, Stepan

Global

Specialty surfactant leaders

LABSA sulphonation

Numerous regional and unorganised sulphonators; captive sulphonation at FMCG majors

India

Price-driven competition (ICRA: low value addition, limited pricing flexibility)

ITeS publishing

Straive (ex-SPi Global), Newgen KnowledgeWorks, Integra, TNQ Technologies, Aptara

India (Chennai cluster)

Larger, specialised publishing-services firms

Peer Comparison FY2026

MetricUPLGalaxy SurfactantsSudarshan Chemical

Revenue from operations (INR Cr)

7755,2489,787

Revenue growth YoY (%)

11.57.1192.5

Operating profit EBITDA (INR Cr)

126497669

EBITDA margin (%)

16.39.56.8

Net profit (INR Cr)

8126741

Net margin (%)

10.45.10.4

Recent Developments

--

Company Snapshot

$89.5M

Revenue

1,256

Employees

1960

Founded

Mumbai, India

Headquarters

SWOT Analysis

Strengths

  • Conservative balance sheet: Gearing 0.1x and interest coverage 16.4x in FY2025 (ICRA); borrowings ₹86 Cr vs equity ₹870 Cr at FY2026
  • Investment-grade credit: [ICRA]A+(Stable)/A1+ reaffirmed 7 Oct 2025
  • Consistent cash generation: CFO rose every year FY2022–FY2026, from ₹29 Cr to ₹128 Cr; FY2026 FCF ₹62 Cr
  • Margin premium to peers: FY2026 EBITDA margin 16.3% vs Galaxy ~9.5% and Sudarshan ~6.8%
  • Long-standing FMCG customer base: ICRA: key surfactant supplier to large MNC FMCG players for many years
  • High-margin ITeS diversification: ITeS FY2026 profit ₹15 Cr on ₹52 Cr income (~29% margin)
  • Consistent dividends: Dividend paid every year reviewed; ₹6/share for FY2025 and FY2026; payout 21–25%
  • Green energy cost advantage: Green power 52% of consumption in FY2026; wind output 80 lakh units

Weaknesses

  • Pigment product concentration: ICRA identifies dependence on ultramarine blue as its main credit constraint
  • Low-margin revenue mix: Surfactants = 63% of FY2026 revenue; EBITDA margin fell from ~25% (FY2020–21) to 16–18%
  • Low headline returns: ROE 7–9% FY2022–FY2026; Screener 3-year ROE 7.9%
  • Parent pigment revenue decline: Standalone pigments fell from ₹175 Cr to ₹164 Cr in FY2026
  • Under-utilised new capacity: USCL CICP plant below anticipated utilisation in FY2026 (Directors' Report)
  • Limited disclosure: No earnings calls, guidance, R&D spend or segment margin disclosure in reviewed sources; BRSR not mandatory
  • Earnings volatility quarter to quarter: PAT ranged ₹14.15 Cr (Q4 FY26) to ₹31.59 Cr (Q1 FY27) within two quarters

Opportunities

  • Greenfield pigment capacity: ₹250 Cr, 2,500 MTPA Manapparai plant (approved 20 May 2026) raises group pigment capacity ~25% vs 9,715 MTPA
  • Specialty surfactants upgrade: Eight specialty products already in catalogue; new product commercialised FY2026
  • Export recovery: Management expects lower US tariffs to support export growth; subsidiary exports rose to ~₹50 Cr
  • Heavy-metal-free pigment substitution: BiVaN (PY184) portfolio positioned for lead/cadmium replacement
  • Operating leverage on USCL: 3,550 MTPA capacity in place; utilisation upside from FY2026 base
  • Q1 FY2027 momentum: Revenue +30%, PAT +56%, OPM 18.95%
  • Rerating from low base: P/E ~13x TTM, P/B ~1.3x (5paisa, Oct 2026)

Threats

  • Input-cost shocks: Q4 FY2026 margins hit by steep input price rises after West Asia events
  • Trade barriers: US tariffs reduced parent exports from ₹184 Cr to ₹176 Cr in FY2026
  • Global competitor consolidation: Mutares acquired Holliday Pigments (2026) planning higher-grade capacity investment
  • Related-party exposure: ₹45 Cr TCL equity subscription (Dec 2025) + ₹65 Cr unsecured loan (Apr 2026); TCL reported a wider consolidated loss in FY2026
  • Mark-to-market equity risk: Reserves fell ₹103 Cr in FY2026 despite ₹81 Cr PAT, consistent with TCL stake decline
  • Environmental/regulatory tightening: ICRA flags low-frequency, high-impact EHS and litigation risks for chemical manufacturers
  • AI disruption of ITeS: Publishing and billing work increasingly automatable (industry trend; not quantified)

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Key Developments

DateEventSignificance
21 May 2025FY2025 results: consolidated revenue ₹694.71 Cr (+24%), PAT ₹75.05 Cr (+30%); Q4 PAT ₹17.02 Cr (+57%)Strong recovery year after flat FY2024
21 May 2025Final dividend of ₹6 (300%) recommended, up from ₹5First dividend increase in several years
16 Jul 2025Record date for FY2025 dividendPayout executed
21 Jul 2025Shares hit all-time high of ₹613.95Peak valuation; stock since down ~33%
23 Jul 2025Q1 FY2026: revenue ₹184.38 Cr (+13% on sales basis), PAT ₹20.19 Cr (+22%); ₹551 Cr unrealised OCI gain on investmentsOCI swing shows TCL-stake volatility
Jul 2025USCL recommends 7.5% preference dividendUpstreaming of subsidiary cash
7 Oct 2025ICRA reaffirms A+(Stable)/A1+; rated limits enhanced to ₹37.60 CrCredit quality stable
3 Nov 2025ICRA credit perspective report publishedOngoing surveillance
8 Nov 2025Q2 FY2026: sales ₹196.07 Cr (+21.9%, then a record), PAT ₹19.36 Cr (+3.9%); OPM 16.1% vs 16.9%Volume growth, margin compression
21 Nov 2025India's four new Labour Codes take effect₹1.71 Cr one-time gratuity/leave charge in Q3
23 Dec 2025UPL allotted 15,20,270 TCL shares at ₹296 (~₹45 Cr)Related-party capital deployment
29–31 Dec 2025GST order for ₹15.09 lakh interest and penalty (CGST Range-III, Ambattur)Immaterial; appeal under evaluation
Q3 FY2026NHAI compensation for compulsory acquisition of part of factory land (₹5.77 Cr + ₹0.20 Cr interest)One-off gain
11 Feb 2026Q3 FY2026: revenue ₹195.60 Cr (+9.6%), PAT ₹27.09 Cr (+18.5%) incl. exceptional itemsStrongest FY2026 quarter
Mar 2026 (Q4)West Asia geopolitical events trigger sharp input price spikes in pigments and surfactantsQ4 margin squeeze
30 Apr 2026₹65 Cr unsecured loan to TCL (3 yrs, 10%)Governance-sensitive related-party exposure
11 May 2026Board meeting intimation for 20 MayRoutine
20 May 2026FY2026 results: revenue ₹774.77 Cr (+11.5%), PAT ₹80.77 Cr (+7.6%); Q4 PAT ₹14.15 Cr (−17%)Record revenue, softer Q4
20 May 2026₹6 final dividend recommendedDividend held flat
20 May 2026₹250 Cr greenfield pigments plant approved (2,500 MT, Manapparai)Largest capex commitment in company history
23 May 2026Annual secretarial compliance report: full complianceClean governance filing
19 Jun 2026Shares hit 52-week low of ₹364Valuation trough
30 Jun 2026Integrated Annual Report FY2026 and 65th AGM notice issuedDisclosure
14 Jul 2026Record date for ₹6 dividendPayout
22 Jul 202665th AGM (VC/OAVM): all resolutions approvedRoutine
7 Aug 2026Q1 FY2027: revenue ₹239.96 Cr (+30%), PAT ₹31.59 Cr (+56%), OPM 18.95%Record quarter; sharp rebound
1 Sep 2026Shares rise 7.7% intraday to ₹442.85Post-results momentum
5–6 Oct 2026Two SAST Reg. 29(2) disclosures for TCL received by BSEPromoter holding change (details unconfirmed)
Oct 2026Reg. 74(5) certificate for quarter ended 30 Sep 2026 filedRoutine; Q2 FY2027 results expected ~November 2026

Financial Performance

Explore key financial metrics, segmented revenue, balance sheet health, and performance trends.

Revenue

4 charts
Revenue by Segment: Surfactants & Specialities revenue rose from INR 4,300 Mn in FY2025 to INR 4,890 Mn in FY2026.
Ultramarine & Pigments Ltd. — Revenue by Segment
Series (INR Mn)FY2025FY2026
Surfactants & Specialities revenue4,3004,890
Inorganic Pigments — parent revenue1,7501,640
Inorganic Pigments — USCL subsidiary revenue540740
ITeS income450520
Consolidated revenue from operations6,9507,750

Unlock Company Financials

Unlock this company profile to view its financial data.

View Subscription Plans

Sources

Sources

  1. Ultramarine & Pigments Ltd — FY2025-26 Directors' Report (65th Annual Report), via India Infoline (indiainfoline.com)
  2. Company website — About Us, Board, Products · ultramarinepigments.net · ultramarinepigments.net
  3. ICRA rating rationale, 7 Oct 2025 (icra.in)
  4. ICRA rating history page (icra.in)
  5. Screener.in consolidated financials (screener.in)
  6. 5paisa market data and shareholding (Oct 2026) (5paisa.com)
  7. Business Standard — Q4 FY2025 and Q2 FY2026 results; share data · business-standard.com · business-standard.com
  8. ScanX — Q3 FY2026 results and TCL investment (scanx.trade)
  9. Trendlyne — Q4 FY2026 results summary (trendlyne.com)
  10. AskFuzz/Business Standard data — Q1 FY2027 results (askfuzz.ai)
  11. Trade Brains / MoneyWorks4Me — ₹250 Cr greenfield · moneyworks4me.com
  12. BSE filing — SIPCOT lease deed (Dec 2024) (bseindia.com)
  13. NSE filing — Thirumalai Chemicals loan agreement with UPL (30 Apr 2026) (nsearchives.nseindia.com)
  14. Screener — Thirumalai Chemicals (₹65 Cr loan terms) (screener.in)
  15. ScanX — GST order (Jan 2026) (scanx.trade)
  16. ICN — FY2025 results (indianchemicalnews.com)
  17. IIFL — company history summary (indiainfoline.com)
  18. MarketsMojo — shareholders and company CV (marketsmojo.motilaloswal.com)
  19. Fundz (unconfirmed SAST interpretation) (app.fundz.net)
  20. Star Cement NSE filing (Nitesh Minerals — clarifies misattribution) (nsearchives.nseindia.com)
  21. Mutares — Holliday Pigments acquisition (mutares.com)
  22. Galaxy Surfactants FY2026 (anandrathi.com)
  23. Sudarshan Chemical FY2026 (scanx.trade)

Unlock Company Contacts

Connect with Key Decision-Makers

Access verified employee contacts and decision-maker information from this company to support your sales, lead generation, and business development efforts.